Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study

Wen Jing; Liu Chao; Yang Qing; Liu Qiang

doi:doi:10.11648/j.wjph.20230802.12

| Peer-Reviewed

Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study

Wen Jing, Liu Chao, Yang Qing, Liu Qiang

Published in World Journal of Public Health (Volume 8, Issue 2)

Received: 19 March 2023 Accepted: 6 April 2023 Published: 15 April 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Research background: Since the gradual liberalization of the epidemic in China in November 2022, economic activities have gradually resumed, the incidence of COVID-19 admitted to our hospital has gradually decreased, the symptoms and the toxicity have gradually decreased. Objective: By analyzing the research and analysis of the treatment of patients infected with COVID-19 infection in the Third People's Hospital of Sichuan Province from December 2022 to February 2023, can help to understand the clinical manifestations of COVID-19 virus infection after the opening of the epidemic in China, and guide patients to standardize medical treatment. The follow-up research and treatment of COVID-19 after the epidemic is released for reference. Research method: inclusion standard: patients with COVID-19 pharyngeal swab test positive. We used the "Case Information System and Prevention and Control System" to carry out statistical analysis and retrospectively study of theCOVID-19 infection since the opening of the epidemic. Research results: In this study, the total number of outpatient visits to respiratory medicine in the Third People's Hospital of Sichuan Province from December 1, 2022 to February 28, 2023 was 4,582 people/90 days. The total hospitalization rate was 7.88% (361/4582), due to the COVID-19 infection is 1.55% (71/4582); men account for 0.94%, women account for 0.61%, and the total mortality rate after hospitalization is 1.10% (4/361), and the total mortality rate of patients after the novel COVID-19 infection is 0. 55% (2/361), as shown in Figure 1, Figure 2 and Figure 3. After national vaccination, the main symptoms of patients infected with COVID-19 are fever, soreness all over the body, mainly lung invasion changes, the number of severe patients and respiratory failure is small, indicating that its toxicity is reduced. With the largest number of cases in the 50-75-year-old group, accounting for 36.61% (26/71) and a mortality rate of 2.82% (2/71). Common with respiratory failure and abnormal liver function. The more complications, the older age, the more days of hospitalization, and the higher cost of hospitalization. Conclusion: Since the vaccination against the COVID-19 in China, the mortality rate due to the COVID-19 in our hospital is low, and the incidence of severe clinical manifestations is low, which shows that the toxicity of COVID-19 infection has gradually decreased with COVID-19 vaccination. This study found that the older patients with multiple complications, the more hospitalization days, the higher the cost of hospitalization. For elderly patients with a variety of complications and complications, recommended to be hospitalized in time.

Published in	World Journal of Public Health (Volume 8, Issue 2)
DOI	10.11648/j.wjph.20230802.12
Page(s)	50-54
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

COVID-19, Epidemiology, Hospitalization Analysis, Fever, Reduced Virulence, Complications, Complications

References

[1]	Sun Sha, Niu Huayong, Yang Dan. Analysis and evaluation of the trend of globalization under the impact of COVID-19 [J]. China Soft Science, 2023, No. 385 (01): 13-21+83.
[2]	Hong Fan. Patent-based research on the development of China's anti-coronavirus infection technology [J]. China Science and Technology Resources Guide, 2023, 55 (01): 99-108.
[3]	Li Xuemeng. From "prevention of infection" to "protection of health, prevention of severe illness" to ensure a smooth transition of epidemic prevention and control [N]. Qinghai Daily, 2023-01-08 (006).
[4]	Zhang Jiaxing. China has emerged from the COVID-19 pandemic [N]. Science and Technology Daily, 2023-02-24 (003).
[5]	Zhiyuan Qiu, Jianqing Zhu, Xinyuan Yan. Analysis on the operation strategy of three-level public hospitals in the epidemic situation of new coronavirus pneumonia [J]. China Hospital administration, 2020, 40 (6): 33-34, 37.
[6]	Dong Xu, Yu Hu, Ning Ding. Analysis on the difficulties and strategies of public hospital operation management under the condition of normal epidemic prevention and control [J]. China Hospital administration, 2020, 40 (8): 25 -28.
[7]	Yu Su. Research on the evolution logic of government attention in the prevention and control of COVID-19 in China [D]. Lanzhou University, 2022. DOI: 10.27204/d.cnki.glzhu.2022.001380.
[8]	Notice of the Joint Prevention and Control Mechanism of the State Council in Response to the Novel Coronavirus Infection Pneumonia Epidemic on Further Improving the Prevention and Control of the Current COVID-19 Epidemic [J]. Bulletin of the State Council of the People's Republic of China, 2021, No. 1723 (04): 13-15.
[9]	Notice of the Joint Prevention and Control Mechanism of the State Council in Response to the Novel Coronavirus-infected Pneumonia Epidemic on Further Improving the Prevention and Control of COVID-19 in Key Units in Key Places [J]. Bulletin of the State Council of the People's Republic of China, 2020, No. 1694 (11): 16-18.
[10]	Wen Huang, Fang Ge. The strategy of Precision Prevention and control management in Nursing Department of General Ward under the normalization of COVID-19 epidemic situation prevention and control [J]. Chinese Journal of Rural Medicine and Pharmacy, March 2022 vol. 29 No. 6: 79-80.
[11]	Shen Li, Dong Yu, Xu Wen, etc. Investigation and analysis of the current hospital infection rate of Delta COVID-19 patients [J]. Chinese Journal of Infection Control, 2022, 21 (08): 749-753.
[12]	Ma Yubo, Jia Tingting, Zhang Ruifen, etc. Thinking about the diagnosis and treatment of traditional Chinese medicine for novel coronavirus infection [J]. Journal of Chinese Medicine, 2023, 41 (02): 19-23. DOI: 10.13193/j.issn.1673-7717.2023.2.005.
[13]	Beijing administration of traditional Chinese medicine. Beijing new coronavirus pneumonia prevention and treatment program of traditional Chinese medicine (fifth edition) [EB/Ol]. (2020-06-16) [2021-04-01] http://www.xinhuanet.com/health/2020-06/17/c-1126125150.htm
[14]	Fu Liu, To analyze the protective measures and experience of senile patients with coronavirus pneumonia [J]. Health Advice, Issue 12, 2020: 171-172.
[15]	Zhang Lina, Peng Qianyi. Expert advice on severe treatment of novel coronavirus infection [J]. Practical Shock Magazine (Chinese and English), 2022, 6 (06): 363-366.
[16]	Na Li, Zhe Wang, Yun-li Bao, Hai-ru Tang, Jun Huang, Xiao-Hui Yu, Jiu-Cong zhang, COVID-19 Sequelae: Clinical Features and Research Progress [J]. Journal of Hainan Medical University-Novel coronavirus prevention and control column, 2022, 28 (14): 1041-1049.

Cite This Article

Plain Text BibTeX RIS

APA Style

Wen Jing, Liu Chao, Yang Qing, Liu Qiang. (2023). Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study. World Journal of Public Health, 8(2), 50-54. https://doi.org/10.11648/j.wjph.20230802.12

Copy | Download

ACS Style

Wen Jing; Liu Chao; Yang Qing; Liu Qiang. Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study. World J. Public Health 2023, 8(2), 50-54. doi: 10.11648/j.wjph.20230802.12

Copy | Download

AMA Style

Wen Jing, Liu Chao, Yang Qing, Liu Qiang. Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study. World J Public Health. 2023;8(2):50-54. doi: 10.11648/j.wjph.20230802.12

Copy | Download

@article{10.11648/j.wjph.20230802.12,
  author = {Wen Jing and Liu Chao and Yang Qing and Liu Qiang},
  title = {Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study},
  journal = {World Journal of Public Health},
  volume = {8},
  number = {2},
  pages = {50-54},
  doi = {10.11648/j.wjph.20230802.12},
  url = {https://doi.org/10.11648/j.wjph.20230802.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20230802.12},
  abstract = {Research background: Since the gradual liberalization of the epidemic in China in November 2022, economic activities have gradually resumed, the incidence of COVID-19 admitted to our hospital has gradually decreased, the symptoms and the toxicity have gradually decreased. Objective: By analyzing the research and analysis of the treatment of patients infected with COVID-19 infection in the Third People's Hospital of Sichuan Province from December 2022 to February 2023, can help to understand the clinical manifestations of COVID-19 virus infection after the opening of the epidemic in China, and guide patients to standardize medical treatment. The follow-up research and treatment of COVID-19 after the epidemic is released for reference. Research method: inclusion standard: patients with COVID-19 pharyngeal swab test positive. We used the "Case Information System and Prevention and Control System" to carry out statistical analysis and retrospectively study of theCOVID-19 infection since the opening of the epidemic. Research results: In this study, the total number of outpatient visits to respiratory medicine in the Third People's Hospital of Sichuan Province from December 1, 2022 to February 28, 2023 was 4,582 people/90 days. The total hospitalization rate was 7.88% (361/4582), due to the COVID-19 infection is 1.55% (71/4582); men account for 0.94%, women account for 0.61%, and the total mortality rate after hospitalization is 1.10% (4/361), and the total mortality rate of patients after the novel COVID-19 infection is 0. 55% (2/361), as shown in Figure 1, Figure 2 and Figure 3. After national vaccination, the main symptoms of patients infected with COVID-19 are fever, soreness all over the body, mainly lung invasion changes, the number of severe patients and respiratory failure is small, indicating that its toxicity is reduced. With the largest number of cases in the 50-75-year-old group, accounting for 36.61% (26/71) and a mortality rate of 2.82% (2/71). Common with respiratory failure and abnormal liver function. The more complications, the older age, the more days of hospitalization, and the higher cost of hospitalization. Conclusion: Since the vaccination against the COVID-19 in China, the mortality rate due to the COVID-19 in our hospital is low, and the incidence of severe clinical manifestations is low, which shows that the toxicity of COVID-19 infection has gradually decreased with COVID-19 vaccination. This study found that the older patients with multiple complications, the more hospitalization days, the higher the cost of hospitalization. For elderly patients with a variety of complications and complications, recommended to be hospitalized in time.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study
AU  - Wen Jing
AU  - Liu Chao
AU  - Yang Qing
AU  - Liu Qiang
Y1  - 2023/04/15
PY  - 2023
N1  - https://doi.org/10.11648/j.wjph.20230802.12
DO  - 10.11648/j.wjph.20230802.12
T2  - World Journal of Public Health
JF  - World Journal of Public Health
JO  - World Journal of Public Health
SP  - 50
EP  - 54
PB  - Science Publishing Group
SN  - 2637-6059
UR  - https://doi.org/10.11648/j.wjph.20230802.12
AB  - Research background: Since the gradual liberalization of the epidemic in China in November 2022, economic activities have gradually resumed, the incidence of COVID-19 admitted to our hospital has gradually decreased, the symptoms and the toxicity have gradually decreased. Objective: By analyzing the research and analysis of the treatment of patients infected with COVID-19 infection in the Third People's Hospital of Sichuan Province from December 2022 to February 2023, can help to understand the clinical manifestations of COVID-19 virus infection after the opening of the epidemic in China, and guide patients to standardize medical treatment. The follow-up research and treatment of COVID-19 after the epidemic is released for reference. Research method: inclusion standard: patients with COVID-19 pharyngeal swab test positive. We used the "Case Information System and Prevention and Control System" to carry out statistical analysis and retrospectively study of theCOVID-19 infection since the opening of the epidemic. Research results: In this study, the total number of outpatient visits to respiratory medicine in the Third People's Hospital of Sichuan Province from December 1, 2022 to February 28, 2023 was 4,582 people/90 days. The total hospitalization rate was 7.88% (361/4582), due to the COVID-19 infection is 1.55% (71/4582); men account for 0.94%, women account for 0.61%, and the total mortality rate after hospitalization is 1.10% (4/361), and the total mortality rate of patients after the novel COVID-19 infection is 0. 55% (2/361), as shown in Figure 1, Figure 2 and Figure 3. After national vaccination, the main symptoms of patients infected with COVID-19 are fever, soreness all over the body, mainly lung invasion changes, the number of severe patients and respiratory failure is small, indicating that its toxicity is reduced. With the largest number of cases in the 50-75-year-old group, accounting for 36.61% (26/71) and a mortality rate of 2.82% (2/71). Common with respiratory failure and abnormal liver function. The more complications, the older age, the more days of hospitalization, and the higher cost of hospitalization. Conclusion: Since the vaccination against the COVID-19 in China, the mortality rate due to the COVID-19 in our hospital is low, and the incidence of severe clinical manifestations is low, which shows that the toxicity of COVID-19 infection has gradually decreased with COVID-19 vaccination. This study found that the older patients with multiple complications, the more hospitalization days, the higher the cost of hospitalization. For elderly patients with a variety of complications and complications, recommended to be hospitalized in time.
VL  - 8
IS  - 2
ER  -

Copy | Download

Author Information

Wen Jing

Department of Respiratory Medicine, Sichuan Third People's Hospital, Chengdu, China
Liu Chao

Department of Clinical Medicine, Specialization of Surgery, Faculty of Medicine, Dentistry, and Health Science, Universitas Indonesia (Prima), Medan, Indonesia
Yang Qing

Department of Critical Care Medicine, Jiangyou 903 Hospital, Jiangyou, China
Liu Qiang

Department of Respiratory Medicine, Sichuan Third People's Hospital, Chengdu, China

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Wen Jing, Liu Chao, Yang Qing, Liu Qiang. (2023). Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study. World Journal of Public Health, 8(2), 50-54. https://doi.org/10.11648/j.wjph.20230802.12

Copy | Download

ACS Style

Wen Jing; Liu Chao; Yang Qing; Liu Qiang. Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study. World J. Public Health 2023, 8(2), 50-54. doi: 10.11648/j.wjph.20230802.12

Copy | Download

AMA Style

Wen Jing, Liu Chao, Yang Qing, Liu Qiang. Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study. World J Public Health. 2023;8(2):50-54. doi: 10.11648/j.wjph.20230802.12

Copy | Download

@article{10.11648/j.wjph.20230802.12,
  author = {Wen Jing and Liu Chao and Yang Qing and Liu Qiang},
  title = {Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study},
  journal = {World Journal of Public Health},
  volume = {8},
  number = {2},
  pages = {50-54},
  doi = {10.11648/j.wjph.20230802.12},
  url = {https://doi.org/10.11648/j.wjph.20230802.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20230802.12},
  abstract = {Research background: Since the gradual liberalization of the epidemic in China in November 2022, economic activities have gradually resumed, the incidence of COVID-19 admitted to our hospital has gradually decreased, the symptoms and the toxicity have gradually decreased. Objective: By analyzing the research and analysis of the treatment of patients infected with COVID-19 infection in the Third People's Hospital of Sichuan Province from December 2022 to February 2023, can help to understand the clinical manifestations of COVID-19 virus infection after the opening of the epidemic in China, and guide patients to standardize medical treatment. The follow-up research and treatment of COVID-19 after the epidemic is released for reference. Research method: inclusion standard: patients with COVID-19 pharyngeal swab test positive. We used the "Case Information System and Prevention and Control System" to carry out statistical analysis and retrospectively study of theCOVID-19 infection since the opening of the epidemic. Research results: In this study, the total number of outpatient visits to respiratory medicine in the Third People's Hospital of Sichuan Province from December 1, 2022 to February 28, 2023 was 4,582 people/90 days. The total hospitalization rate was 7.88% (361/4582), due to the COVID-19 infection is 1.55% (71/4582); men account for 0.94%, women account for 0.61%, and the total mortality rate after hospitalization is 1.10% (4/361), and the total mortality rate of patients after the novel COVID-19 infection is 0. 55% (2/361), as shown in Figure 1, Figure 2 and Figure 3. After national vaccination, the main symptoms of patients infected with COVID-19 are fever, soreness all over the body, mainly lung invasion changes, the number of severe patients and respiratory failure is small, indicating that its toxicity is reduced. With the largest number of cases in the 50-75-year-old group, accounting for 36.61% (26/71) and a mortality rate of 2.82% (2/71). Common with respiratory failure and abnormal liver function. The more complications, the older age, the more days of hospitalization, and the higher cost of hospitalization. Conclusion: Since the vaccination against the COVID-19 in China, the mortality rate due to the COVID-19 in our hospital is low, and the incidence of severe clinical manifestations is low, which shows that the toxicity of COVID-19 infection has gradually decreased with COVID-19 vaccination. This study found that the older patients with multiple complications, the more hospitalization days, the higher the cost of hospitalization. For elderly patients with a variety of complications and complications, recommended to be hospitalized in time.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Research and Analysis on the Diagnosis and Treatment of COVID-19 Patients After the Full Opening of Epidemic Prevention and Control - A Population Based Study
AU  - Wen Jing
AU  - Liu Chao
AU  - Yang Qing
AU  - Liu Qiang
Y1  - 2023/04/15
PY  - 2023
N1  - https://doi.org/10.11648/j.wjph.20230802.12
DO  - 10.11648/j.wjph.20230802.12
T2  - World Journal of Public Health
JF  - World Journal of Public Health
JO  - World Journal of Public Health
SP  - 50
EP  - 54
PB  - Science Publishing Group
SN  - 2637-6059
UR  - https://doi.org/10.11648/j.wjph.20230802.12
AB  - Research background: Since the gradual liberalization of the epidemic in China in November 2022, economic activities have gradually resumed, the incidence of COVID-19 admitted to our hospital has gradually decreased, the symptoms and the toxicity have gradually decreased. Objective: By analyzing the research and analysis of the treatment of patients infected with COVID-19 infection in the Third People's Hospital of Sichuan Province from December 2022 to February 2023, can help to understand the clinical manifestations of COVID-19 virus infection after the opening of the epidemic in China, and guide patients to standardize medical treatment. The follow-up research and treatment of COVID-19 after the epidemic is released for reference. Research method: inclusion standard: patients with COVID-19 pharyngeal swab test positive. We used the "Case Information System and Prevention and Control System" to carry out statistical analysis and retrospectively study of theCOVID-19 infection since the opening of the epidemic. Research results: In this study, the total number of outpatient visits to respiratory medicine in the Third People's Hospital of Sichuan Province from December 1, 2022 to February 28, 2023 was 4,582 people/90 days. The total hospitalization rate was 7.88% (361/4582), due to the COVID-19 infection is 1.55% (71/4582); men account for 0.94%, women account for 0.61%, and the total mortality rate after hospitalization is 1.10% (4/361), and the total mortality rate of patients after the novel COVID-19 infection is 0. 55% (2/361), as shown in Figure 1, Figure 2 and Figure 3. After national vaccination, the main symptoms of patients infected with COVID-19 are fever, soreness all over the body, mainly lung invasion changes, the number of severe patients and respiratory failure is small, indicating that its toxicity is reduced. With the largest number of cases in the 50-75-year-old group, accounting for 36.61% (26/71) and a mortality rate of 2.82% (2/71). Common with respiratory failure and abnormal liver function. The more complications, the older age, the more days of hospitalization, and the higher cost of hospitalization. Conclusion: Since the vaccination against the COVID-19 in China, the mortality rate due to the COVID-19 in our hospital is low, and the incidence of severe clinical manifestations is low, which shows that the toxicity of COVID-19 infection has gradually decreased with COVID-19 vaccination. This study found that the older patients with multiple complications, the more hospitalization days, the higher the cost of hospitalization. For elderly patients with a variety of complications and complications, recommended to be hospitalized in time.
VL  - 8
IS  - 2
ER  -

Copy | Download